Pharmaceutical prices in the 21st century [electronic resource] / Zaheer-Ud-Din Babar, editor.
2015
HD9665.4 .P43 2015eb
Linked e-resources
Linked Resource
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Details
Title
Pharmaceutical prices in the 21st century [electronic resource] / Zaheer-Ud-Din Babar, editor.
ISBN
9783319121697 electronic book
3319121693 electronic book
9783319121680
3319121693 electronic book
9783319121680
Published
[Auckland] : Adis ; Cham ; Heidelberg ; New York ; Dordrecht ; London : Springer, [2015]
Copyright
©2015
Language
English
Description
1 online resource.
Item Number
10.1007/978-3-319-12169-7 doi
Call Number
HD9665.4 .P43 2015eb
Dewey Decimal Classification
338.436151
Summary
The book is an essential, comprehensive text onglobal drug pricing and covers a range of pharmaceutical pricing issues. It has twenty-two chapters in total;nineteenof which are case studieson an array of high, middle, and low income countries. The final three chaptersdiscussvalue-based pricing, innovation, prices and the pharmaceutical industry and the link betweenpharmaceutical policy and pricing. As the pharmaceutical market continues to expand, a number of pharmaceutical pricing strategies have been employed to control drug expenditures. The book explores this phenomenon further and willserve a valuable resource for policy makers, funders, social insurance institutions and drug companies. ℗ℓAbout the author Zaheer-Ud-Din Babar, PhD is the Head of Pharmacy Practice at the School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. A pharmacist by training and a PhD in pharmaceutical policy, Dr Babar is a recipient of the prestigious ℓ́ℓResearch Excellence Awardℓ́ℓ from the University of Auckland. His research program covers areas related to pharmaceutical policy and practice, encompassing access to and affordability of medicines, issues related to medicine pricing and pharmacoeconomics. Dr Babar has delivered invited lectures at Boston University School of Public Health, Harvard Medical School, the Austrian Health Institute and the Universities of Reading and Kingston. He has also acted as a consultant for the World Health Organization, Health Action International, the International Union against Tuberculosis and Lung Disease, the International Pharmaceutical Federation (FIP) and the Pharmaceutical Management Agency of New Zealand in the area of medicines pricing and policies. Dr Babar is the Editor in Chief of the Journal of Pharmaceutical Policy and Practice,℗ℓwww.joppp.org and can be reached at z.babar@auckland.ac.nz.
Bibliography, etc. Note
Includes bibliographical references.
Access Note
Access limited to authorized users.
Added Author
Available in Other Form
Linked Resources
Record Appears in
Table of Contents
Introduction
Reference pricing strategies
Differential pricing
Prices of vaccines.
Reference pricing strategies
Differential pricing
Prices of vaccines.